Is undecylenic acid effective against fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Undecylenic Acid Kill Fungus?

Yes, undecylenic acid is an FDA-approved antifungal agent that effectively kills fungi, particularly dermatophytes causing superficial skin infections like tinea pedis (athlete's foot), though it is less effective than modern systemic antifungals and should not be used for nail infections. 1

Mechanism and Efficacy

Undecylenic acid functions as a fungicidal agent by disrupting fungal cell membranes and inhibiting critical virulence factors 2:

  • Direct antifungal activity: Undecylenic acid permeabilizes fungal cell membranes, causing cell death in susceptible organisms 2
  • Inhibits biofilm formation: At concentrations above 3 mM, it effectively prevents Candida albicans biofilm development 2
  • Blocks morphological transition: At concentrations above 4 mM, it abolishes the yeast-to-filamentous phase transition in Candida, a key virulence mechanism 2
  • Reduces virulence factors: It decreases transcription of hydrolytic enzymes (secreted aspartic protease, lipase, phospholipase) and hyphal formation genes like HWP1 2

Clinical Evidence for Effectiveness

Tinea Pedis (Athlete's Foot)

  • In a controlled clinical trial of 104 patients with mycologically confirmed tinea pedis, undecylenic acid powder achieved clinical and mycological cure in 53% of patients compared to only 7% in untreated controls 3
  • This represents a safe and effective treatment option for superficial foot fungal infections 3

Candida Infections

  • Novel hexosome formulations with undecylenic acid demonstrated minimal inhibitory concentrations for 50% and 90% Candida growth reduction at 0.01 and 0.16 wt%, respectively 4
  • These formulations reduced metabolically active Candida by 72-96% and were non-toxic to human cells 4

Important Clinical Limitations

Not Recommended for Nail Infections

  • The British Journal of Dermatology guidelines explicitly state there are no published studies on the efficacy of undecylenic acid (methyl undecenoate preparations) in fungal nail infections, and its use cannot be recommended for onychomycosis 5
  • Systemic therapy with terbinafine or itraconazole is almost always more successful than topical treatment for nail infections 5

Inferior to Modern Antifungals

  • While undecylenic acid is classified among "nonspecific agents" that remain effective in many situations, modern specific antifungal agents (imidazoles like miconazole, allylamines like terbinafine) have primary fungicidal effects and can be used in lower concentrations with shorter therapeutic courses 6
  • For most mycotic infections, topical miconazole is considered a relatively more effective agent 6

Appropriate Clinical Use

Use undecylenic acid for:

  • Superficial dermatophyte infections, particularly tinea pedis 3
  • Mild fungal skin infections where modern antifungals are unavailable or cost-prohibitive 6
  • Over-the-counter self-treatment of minor fungal skin conditions 1

Do NOT use undecylenic acid for:

  • Onychomycosis (nail fungal infections) - use oral terbinafine or itraconazole instead 5
  • Invasive or systemic fungal infections - use fluconazole, echinocandins, or amphotericin B formulations 5
  • Severe or extensive superficial infections - consider modern topical azoles or allylamines 6

Common Pitfalls to Avoid

  • Do not rely on undecylenic acid for nail infections - this is a common mistake, as it lacks evidence for efficacy in onychomycosis despite being marketed for this indication 5
  • Confirm diagnosis mycologically before treatment - clinical diagnosis alone leads to high treatment failure rates 7, 8
  • Consider that undecylenic acid's oily nature limits its solubility and practical application - newer formulations (hexosomes) may improve delivery but are not yet widely available 4

References

Research

Antifungal effects of undecylenic acid on the biofilm formation of Candida albicans.

International journal of clinical pharmacology and therapeutics, 2016

Research

Topical undecylenic acid in tinea pedis: a new look.

International journal of dermatology, 1977

Research

Hexosomes with Undecylenic Acid Efficient against Candida albicans.

Nanomaterials (Basel, Switzerland), 2018

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Topical antifungal agents: an update.

American family physician, 1996

Guideline

Efinaconazole Treatment for Fingernail Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oral Treatment for Nail Fungal Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended treatment for skin infections requiring both antifungal and antibiotic coverage?
What is axillary fungal infection?
Is it safe to prescribe miconazole cream or clotrimazole cream to a patient with allergies to amoxicillin (a type of penicillin antibiotic) and levofloxacin (a type of fluoroquinolone antibiotic) for a fungal infection?
What cream is used to treat skin fungal infections?
What is the appropriate treatment for a 6-year-old child with a round rash that has a white center, suggestive of a fungal infection, such as ringworm (tinea corporis)?
What are the serum creatinine and Glomerular Filtration Rate (GFR) thresholds for initiating Eliquis (apixaban) in a patient with impaired renal function?
What is the recommended management plan for a 23-year-old patient with hypertension, who has undergone a vascular US (Ultrasound) duplex renal artery/venous bilateral study, showing no evidence of stenosis of the renal arteries, normal kidney size and function, and no ectasia in the distal aorta?
What is the appropriate management for a patient with elevated parathyroid hormone (PTH) levels and normal calcium levels?
What is the first-line treatment for a patient with Obsessive-Compulsive Disorder, Somatic Subtype (F42)?
What is the recommended management for a 36-year-old patient with a history of cholecystectomy who is experiencing improved right upper quadrant symptoms, with ultrasound findings showing no bile duct dilatation and a simple cyst in the midpole of the right kidney?
Will antihistamine eye drops help a patient with viral conjunctivitis, presenting with bilateral eye itchiness and redness, and no known allergies or medical history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.